These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 201353)
1. Effect of the inhibitor of angiotensin I converting enzyme on endocrine function and renal perfusion in haemorrhagic shock. Yamashita M; Oyama T; Kudo T Can Anaesth Soc J; 1977 Nov; 24(6):695-701. PubMed ID: 201353 [TBL] [Abstract][Full Text] [Related]
2. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903 [TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock. Morton JJ; Semple PF; Ledingham IM; Stuart B; Tehrani MA; Garcia AR; McGarrity G Circ Res; 1977 Sep; 41(3):301-8. PubMed ID: 890886 [TBL] [Abstract][Full Text] [Related]
4. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Kimbrough HM; Vaughan ED; Carey RM; Ayers CR Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213 [TBL] [Abstract][Full Text] [Related]
5. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats. Harris PJ; Munro JO J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor. Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615 [TBL] [Abstract][Full Text] [Related]
7. Failure of chronic administration of the angiotensin I-converting enzyme inhibitor, Teprotide (SQ 20881), to affect the ultrastructure of the adrenal cortex and the aldosterone secretion in the rat. Weaver J; Nickerson PA; Molteni A; Solliday N; Albertson D Lab Invest; 1981 Dec; 45(6):527-33. PubMed ID: 6172661 [TBL] [Abstract][Full Text] [Related]
8. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405 [TBL] [Abstract][Full Text] [Related]
9. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
10. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide. VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971 [TBL] [Abstract][Full Text] [Related]
12. Accentuated vascular and endocrine response to SQ 20881 in hypertension. Williams GH; Hollenberg NK N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203 [TBL] [Abstract][Full Text] [Related]
13. Hypotensive effects of the renin inhibitor (RI-78) and the converting enzyme inhibitor (teprotide) in conscious monkeys. Takaori K; Hartley LH; Burton J Clin Exp Hypertens A; 1987; 9(2-3):387-90. PubMed ID: 3038400 [TBL] [Abstract][Full Text] [Related]
14. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274 [No Abstract] [Full Text] [Related]
16. Effects of converting enzyme inhibitor (SQ 20881) on changes in blood pressure and plasma aldosterone induced by angiotensin I or acute hemorrhage in rabbits. Saito I; Eguchi T; Nakamura R; Misumi J; Kondo K; Saruta T Jpn Heart J; 1980 Jan; 21(1):95-101. PubMed ID: 6154159 [TBL] [Abstract][Full Text] [Related]
17. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin II blockade and the functions of the renin-angiotensin system. Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202 [TBL] [Abstract][Full Text] [Related]
19. Action of angiotensin I converting enzyme inhibitor on the control of renal function in the cat. Johns EJ Clin Sci (Lond); 1979 Apr; 56(4):365-71. PubMed ID: 225092 [No Abstract] [Full Text] [Related]
20. The inhibition of rat renin in sodium depleted and renal hypertensive rats. Comparison of purified antibodies or Fab fragments against mouse submaxillary renin with SQ 20881, and the effect on blood pressure homeostasis. Lykkegård S Scand J Urol Nephrol Suppl; 1984; 79():17-22. PubMed ID: 6206557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]